Physician profile
Meredith Kitchell
NPI 1457760084
$2,039.05
in general payments reported to CMS, 2019-2025
21 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.87 · 2022: $12.97 · 2023: $886 · 2024: $625 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,909.21 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $298.09 | 2023-2025 | |
| Astellas Pharma US INC | $271.16 | 2023 | Veozah, Myrbetriq |
| Lilly USA, LLC | $233.45 | 2023-2025 | Mounjaro, Zepbound |
| Sumitomo Pharma America, INC. | $225.34 | 2023-2025 | Gemtesa, Myfembree |
| Mayne Pharma Commercial LLC | $160.50 | 2023-2025 | |
| Pfizer INC. | $118.01 | 2021-2023 | |
| Radius Health, INC. | $110.34 | 2023-2024 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $74.69 | 2023-2025 | |
| Exact Sciences Corporation | $74.67 | 2024-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $74.60 | 2024-2025 | Ozempic, Wegovy |
| Scilex Pharmaceuticals INC. | $59.95 | 2024 | |
| Medtronic, INC. | $58.53 | 2023 | Closurefast, Interstim |
| Baxter Healthcare | $47.46 | 2024 | Floseal |
| Valencia Technologies Corporation | $45.02 | 2025 | Ecoin Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.02 | 2025 | Xifaxan |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $35.85 | 2021-2023 | Prolia, Evenity |
| Organon LLC | $25.86 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.00 | 2023 | |
| Hologic Sales and Service, LLC | $24.19 | 2023 | Aptima, Thinprep 2000 Processor |
| Cosette Pharmaceuticals INC. | $23.82 | 2025 | Vyleesi |
| Idorsia Pharmaceuticals US INC | $13.50 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Kitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.